Literature DB >> 2246035

Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure.

K Shimada1, A Kawamoto, K Matsubayashi, T Ozawa.   

Abstract

Does the average daily blood pressure correlate with hypertensive cerebrovascular disease better than the casual pressure, as has been reported in other target organ involvement? We investigated the associations of two abnormal findings on brain magnetic resonance imaging suggestive of a vascular etiology, low intense foci (lacunae), and periventricular hyperintense lesions on T1- and T2-weighted images, with both office and average daily blood pressure values in a population of 73 healthy normotensive and hypertensive elderly individuals (70 +/- 6 years old). Lacunae were detected in 34 subjects (47%); the number per subject ranged from 0 to 19 and was significantly correlated with advancing age. Furthermore, these changes were supposedly related to the average of noninvasive ambulatory (24-hour and during awake and asleep periods) pressure recordings but not to office pressures. The grade of periventricular hyperintensity was also significantly associated with advancing age and the average of ambulatory systolic pressure recordings, particularly during sleep, but not with office blood pressure. In comparisons of normotensive, "office hypertensive," and hypertensive subgroups, abnormalities on magnetic resonance imaging were appropriate to the level of the 24-hour blood pressure measurements but not to that of clinic pressure. In hypertensive patients, the presence of electrocardiographic evidence of left ventricular hypertrophy was also associated with greater abnormalities on magnetic resonance imaging. We conclude that ambulatory blood pressure monitoring is superior to casual pressure measurements in predicting latent cerebrovascular disease, which is unexpectedly common in apparently healthy elderly subjects.

Entities:  

Mesh:

Year:  1990        PMID: 2246035     DOI: 10.1161/01.hyp.16.6.692

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  The feasibility of quantitative MRI of perivascular spaces at 7T.

Authors:  Kejia Cai; Rongwen Tain; Sandhitsu Das; Frederick C Damen; Yi Sui; Tibor Valyi-Nagy; Mark A Elliott; Xiaohong J Zhou
Journal:  J Neurosci Methods       Date:  2015-09-08       Impact factor: 2.390

Review 2.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

3.  Ultrasonographically assessed carotid intima-media thickness and risk for asymptomatic cerebral infarction.

Authors:  M Yamakado; I Fukuda; H Kiyose
Journal:  J Med Syst       Date:  1998-02       Impact factor: 4.460

Review 4.  Does blood pressure variability modulate cardiovascular risk?

Authors:  Peter M Rothwell
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 5.  Ambulatory blood pressure monitoring: a guide for general practitioners.

Authors:  N Prasad; C Isles
Journal:  BMJ       Date:  1996-12-14

Review 6.  Cerebral white matter lesions in essential hypertension.

Authors:  C Sierra
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 7.  Utility of ambulatory blood pressure monitoring in children and adolescents.

Authors:  John W Graves; Mohammed Mahdi Althaf
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

8.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.

Authors:  A M J Maclullich; J M Wardlaw; K J Ferguson; J M Starr; J R Seckl; I J Deary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 9.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

Review 10.  Ambulatory blood pressure monitoring.

Authors:  G Mancia; S Omboni; A Ravogli; A Frattola; A Villani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.